IPOX Schuster IPOX Schuster

Nikkei: IPOX® Research Associate Lukas Muehlbauer comments on GrabAGun

Japan’s largest financial newspaper, Nikkei, featured IPOX® Research Associate Lukas Muehlbauer in coverage of “Trump stocks.” The piece highlighted GrabAGun Digital Holdings, which announced a $20 million share repurchase after its post-listing performance declined. Muehlbauer noted that while Donald Trump Jr.’s endorsement can help raise brand awareness, investors will ultimately focus on the company’s ability to deliver sustainable growth.

Read More
IPOX Schuster IPOX Schuster

Bloomberg: IPOX® Founder Josef Schuster Comments on Circle’s Opportunistic Early Share Sale

Circle Internet Group is selling 10 million shares just two months after its IPO, capitalizing on a 349% stock surge. IPOX® founder Josef Schuster called it “an opportunistic move… that’s how risk gets transferred into public market.” The oversubscribed offering highlights strong investor demand despite the unusually short lock-up timeline.

Read More
IPOX Schuster IPOX Schuster

Bloomberg: IPOX®’s Lukas Muehlbauer on Europe’s Potential IPO Revival

Europe’s IPO market may be set for a revival, with major listings from Navoi Mining, Visma, Verisure, and Czechoslovak Group on the horizon. After years of sluggish activity, improving market depth and sector momentum could reopen the deal window. IPOX®’s Lukas Muehlbauer says early successes will be key to sustaining activity. Read Bloomberg’s full coverage and IPOX®’s market insight.

Read More
IPOX Schuster IPOX Schuster

Money Life with Chuck Jaffe: IPOX® CEO Josef Schuster on the State of the IPO Market

In an interview with Money Life Podcast, IPOX® CEO Josef Schuster describes the IPO market as bullish and strong, driven by the performance of recent offerings. He notes that SPACs have returned and are a permanent fixture for companies going public. Schuster also highlights an innovative IPOX high-dividend strategy, which capitalizes on mispriced, income-generating companies. He suggests post-IPO investing can be a more liquid and cost-effective alternative to private equity.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 8/8/2025

Global IPO activity remains vibrant across regions, with the U.S. eyeing mega listings like Fannie Mae, Freddie Mac, and OpenAI. Europe readies Thyssenkrupp’s TKMS spin-off, while Asia-Pacific sees Hong Kong and China reviving big deals, including Aux Electric and Huayan Robotics. In MENA, Emirates Global Aluminium and Etihad Airways prepare billion-dollar offerings, alongside Saudi Arabia’s oversubscribed Dar Al Majed real estate IPO.

Read More
IPOX Schuster IPOX Schuster

CNBC: IPOX® Analyst Lukas Muehlbauer on the Resurgence of Space IPOs

In a CNBC feature on the renewed momentum in space-related IPOs, IPOX® Research Associate Lukas Muehlbauer provided expert commentary on current market dynamics. He noted it is “definitely a good time for Space IPOs,” explaining that while government contracts provide insulation from tariffs, dependency on foreign components remains a vulnerability. Muehlbauer also highlighted how increased competition will lower entry barriers for new business models.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on Heartflow’s Upsized IPO

In a Reuters article covering Heartflow's upsized U.S. initial public offering, IPOX® Research Associate Lukas Muehlbauer provided expert analysis on the rebounding medtech IPO market. He noted that Heartflow's success "stands out, with the tightened price range indicating a well-covered book and strong demand," signaling positive momentum for the sector after a multi-year downturn.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Research Associate Lukas Muehlbauer on Firefly Aerospace IPO and Market Outlook

In a Reuters article about Firefly Aerospace’s upsized IPO, IPOX® Research Analyst Lukas Muehlbauer provided expert commentary. He explained that the narrower price range signals “well-covered books on high demand and strong pricing conviction.” Muehlbauer also noted that potential rate relief should cushion volatility and allow the positive IPO market sentiment to continue into the fall.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® Research Associate Lukas Muehlbauer on Lummus Technology's IPO Filing

In a Reuters report on Lummus Technology’s confidential IPO filing, IPOX® Research Associate Lukas Muehlbauer explained the firm's strategic appeal. He highlighted its high-margin revenue model from technology licensing and recurring royalties, positioning Lummus as an attractive alternative to capital-intensive energy operators that own heavy assets, especially given the current U.S. domestic energy push.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® CEO Josef Schuster Comments on Rare Exchange IPO of MIAX

Discussing the rare IPO of exchange operator MIAX, IPOX® CEO Josef Schuster told Reuters there is “strong appetite for U.S. domiciled specialty IPOs.” He offered a balanced view, noting that while MIAX should benefit from this trend, its valuation could be impacted by the fact that it is “not a pure growth deal.”

Read More
IPOX Schuster IPOX Schuster

ETFMarknaden.se: How to Gain Exposure to IPOs Using IPOX® ETFs

Swedish financial outlet ETFMarknaden.se highlighted how investors can access the IPO market using the IPOX®-linked ETFs. The article explains these funds are designed to capture the early growth of newly listed firms, a phase traditional index funds often miss. It specifically identifies the IPOX®-linked First Trust U.S. (FPX) and European (IPXE) Equity Opportunities UCITS ETFs as key vehicles.

Read More
IPOX Schuster IPOX Schuster

The IPOX® Update 8/2/2025

Global IPO markets show strong activity across sectors. In the U.S., fintech giants Klarna and South Korea's Viva Republica are planning billion-dollar listings, signaling robust investor appetite. Europe is poised for major deals, including a potential £5 billion exit for RAC and Unilever's spin-off of its Magnum ice cream division. Activity also remains solid in Asia and MENA.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® CEO Josef Schuster on Heartflow's IPO and the Medtech Rebound

In a Reuters article covering the IPO of medtech firm Heartflow, IPOX® CEO Josef Schuster provided expert commentary on the upcoming listing. Schuster noted Heartflow's "strong top-line growth and high gross margins position it well for initial investor interest," but cautioned that "broader market volatility" could lead to investor caution beyond the first day of trading.

Read More
IPOX Schuster IPOX Schuster

Reuters: IPOX® VP Kat Liu on Investor Appetite for Figma's IPO

In a Reuters article covering Figma's increased IPO valuation target of $18.8 billion, IPOX® Vice President Kat Liu provided commentary on the strong investor appetite for the offering. The article notes the high demand for technology stocks with solid fundamentals. Highlighting the key driver behind the interest, Liu stated, "Investors are responding to companies with credible AI exposure and Figma has done a good job aligning itself with the theme."

Read More